Hester Biosciences Limited has informed the Exchange about schedule of teleconference call for all the investors

24 July 2025

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai 400 051

Scrip Code: 524669

Symbol: HESTERBIO

Dear Sir/ Madam:

Subject: Intimation of earnings conference call

This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor interaction through a teleconference call for all the investors on Friday, 1 August 2025 at 2:00 p.m. (IST), post the announcement of financial results for the quarter ended 30 June 2025. Details for joining the call are attached herewith.

You are requested to take the above on record.

Sincerely For Hester Biosciences Limited

Vinod Mali Company Secretary & Compliance Officer

is pleased to invite you to the

Q1FY26 Results Conference Call

of

Hester Biosciences Limited

Represented by

\

Mr. Rajiv Gandhi, CEO & Managing Director

Ms. Priya Gandhi, Executive Director

Mr. Divyesh Maru, Chief Financial Officer

on

Friday, August 1, 2025

at 14:00 hrs India Time

Diamond Pass registration link: Copy this Link in your browser: Link

Call Co-ordinator:

Mr. Jaideep Goswami, Head of Equities: Email: Jaideep.goswami@icicisecurities.com

Mr. Abdulkader Puranwala: Phone: +91 22 6807 7339, e-mail: abdulkader.puranwala@icicisecurities.com

For any clarification, please contact:

Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: rushad.kapadia@icicisecurities.com

Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: minali.ginwala@icicisecurities.com

Ms. Seema Sehgal: Phone: +91 9871116926, e-mail: seema.sehgal@icicisecurities.com